Urinary CD80 excretion increases in idiopathic minimal-change disease

Journal of the American Society of Nephrology

Volumn 20, Issue 2, 2009, Pages 260-266

  Garin, Eduardo H ^a   Diaz, Leila N ^a   Mu, Wei ^a   Wasserfall, Clive ^a   Araya, Carlos ^a   Segal, Mark ^a   Johnson, Richard J ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; URINE LEVEL;

EID: 59949099339     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007080836     Document Type: Article

References (16)

1. International Study of Kidney Disease in Children: Nephrotic syndrome in children: Prediction of histopathology from clinic and laboratory characteristics at the time of diagnosis. Kidney Int 13: 159-165, 1978
2. Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2: 556-603, 1974
3. Mathieson PW: Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 18[Suppl 6]: 26-29, 2003
4. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40: 453-460, 1991
5. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P: Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397, 2004
6. Reiser J, Mundel P: Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol 15:2246 -2248, 2004
7. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membrane are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J Am Soc Nephrol 16: 408 -416, 2005
8. Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR: B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J Immunol 172: 34 -39, 2004
9. Finger EB, Bluestone JA: When ligand becomes receptor: Tolerance via B7 signaling on DCs. Nat Immunol 3: 1056-1057, 2002
10. Oaks MK, Hallet KM: Cutting edge: A soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164: 5015-5018, 2000
11. Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK: Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18: 1476-1485, 2007
12. Wong CK, Lit LC, Tam LS, Li EK, Lam CW: Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology44: 989-994, 2005
13. Araya C, Garin EH, Mu W, Brusko T, Atkinson M, Johnson RJ: Regulatory T-cell dysfunction in minimal lesion nephrotic syndrome. E-PAS2006;59:4800.7. Available at http://www.abstracts2view.com/pasall/
14. Niemann-Masanek U, Mueller A, Yard BA, Waldherr R, van der Woude FJ: B7-1(CD80) and B7-2(CD86) expression in human tubular epithelial cells in vivo and in vitro. Nephron 92: 542-556, 2002
15. Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. Annu Rev Immunol 23:515-548, 2005
16. Churg J, Habib R, White HR: Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet 760: 1299-1302, 1970